Clinical Trials in Philadelphia

Showing 20521-20540 of 20,904 trials

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

NCT00121381

Atopic dermatitis, also called eczema, is characterized by redness, papulation (skin elevation) and pruritus (skin itching). The active ingredient of pimecrolimus inhibits the T-cell activation. These cells are involved in the inflammatory component of the disease. This study will test the safety of pimecrolimus Cream 1% with topical corticosteroid treatment (commonly used in eczema) in patients with severe atopic dermatitis.

Dermatitis, Atopic

Novartis400 participantsStarted May 2005

Huntington Beach, California, United States • San Diego, California, United States • Denver, Colorado, United States +10 more locations

TERMINATEDPhase 4< 1 mile

Lansoprazole Preventing Gastroduodenal Stress Ulcerations

NCT00220909

The primary objective of this study is to determine whether lansoprazole, administered intravenously, can protect patients undergoing cardiac surgery from the development of and/or progression of previously undetected acid/peptic disorders (erosive esophagitis, gastric ulcer, duodenal ulcer, diffuse gastritis, duodenitis) as measured by the Lanza score and LA classification for esophageal injury. The secondary objectives of this study are: 1. To determine if intravenous lansoprazole protects against the development of clinically important gastrointestinal bleeding in this population (overt bleeding or requiring blood transfusion). 2. To determine if intravenous lansoprazole maintains the intragastric pH above that for placebo throughout the study period.

Patients Undergoing Elective Coronary Artery Bypass Graft

Temple University40 participantsStarted Sep 2005

Philadelphia, Pennsylvania, United States

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

Lansoprazole Preventing Gastroduodenal Stress Ulcerations

Find Trials by Condition in Philadelphia

Rabeprazole Protection of Aspirin Induced Gastric Damage.

A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder

Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma

A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

Thyroid Function in Term Infants With Respiratory Distress

A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma

Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Study of Rebamipide Eye Drops to Treat Dry Eye

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

Study of the NDO Endoscopic Plication System For the Treatment of Symptomatic Gastroesophageal Reflux Disease

Endoscopic Full-Thickness Plication for the Treatment of GERD: Long-Term Multicenter Results